Ischemia and reperfusion--from mechanism to translation.

PubWeight™: 6.64‹?› | Rank: Top 1%

🔗 View Article (PMC 3886192)

Published in Nat Med on November 07, 2011

Authors

Holger K Eltzschig1, Tobias Eckle

Author Affiliations

1: Department of Anesthesiology, Mucosal Inflammation Program, University of Colorado, Aurora, Colorado, USA. holger.eltzschig@ucdenver.edu

Associated clinical trials:

Intra-graft Coagulation Events in Clinical Renal Transplantation and Delayed Graft Function (KTX) | NCT02568696

Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers (DETO2X-bio) | NCT02290080

Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers | NCT02286544

A Randomized Controlled Trial Comparing Non-ischemic to Ischemic Preservation in Adult Cardiac Transplantation (NIHP) | NCT03150147

Study of the Guardian System on Motor Recovery and Impact on Length of Stay in Ischemic Stroke Patients | NCT03673241

RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function | NCT03791476

Algorithm for Apherisis Monitoring and Prescription Assistance in Sickle Cell Patients (ALGODREP) (ALGODREP) | NCT04076683

Trial to Investigate the Effect of Dapagliflozin on Ischemia Reperfusion Induced Endothelial Dysfunction | NCT05217654

Articles citing this

(truncated to the top 100)

Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature (2014) 4.10

Purinergic signaling during inflammation. N Engl J Med (2012) 4.08

Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med (2012) 3.03

Concern Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J Clin Invest (2012) 2.23

Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2013) 2.10

Dendritic cells tolerized with adenosine A₂AR agonist attenuate acute kidney injury. J Clin Invest (2012) 2.00

Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat Med (2012) 1.90

Nucleotide signalling during inflammation. Nature (2014) 1.85

Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans. Thorax (2015) 1.85

Adenosine receptors as drug targets--what are the challenges? Nat Rev Drug Discov (2013) 1.74

Identification of resolvin D2 receptor mediating resolution of infections and organ protection. J Exp Med (2015) 1.71

Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc Natl Acad Sci U S A (2012) 1.70

Retracted Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver. Proc Natl Acad Sci U S A (2013) 1.59

MG53-mediated cell membrane repair protects against acute kidney injury. Sci Transl Med (2015) 1.53

Myocardial ischemia reperfusion injury: from basic science to clinical bedside. Semin Cardiothorac Vasc Anesth (2012) 1.52

Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. Antioxid Redox Signal (2013) 1.48

Activated Protein C Ameliorates Renal Ischemia-Reperfusion Injury by Restricting Y-Box Binding Protein-1 Ubiquitination. J Am Soc Nephrol (2015) 1.48

Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium. Am J Physiol Endocrinol Metab (2014) 1.48

Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. PLoS One (2016) 1.39

Ischaemia-reperfusion injury in liver transplantation--from bench to bedside. Nat Rev Gastroenterol Hepatol (2012) 1.39

The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. J Clin Invest (2014) 1.35

Perioperative organ injury. Anesthesiology (2013) 1.27

The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circ Res (2016) 1.27

Strategies for optimizing the response of cancer and normal tissues to radiation. Nat Rev Drug Discov (2013) 1.25

Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol (2015) 1.19

Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function. Immunol Res (2013) 1.19

Post-ischemic inflammation in the brain. Front Immunol (2012) 1.18

The emerging roles of microRNAs in CNS injuries. Nat Rev Neurol (2013) 1.18

Hypoxic regulation of hand1 controls the fetal-neonatal switch in cardiac metabolism. PLoS Biol (2013) 1.18

TLR2 and TLR4 in the brain injury caused by cerebral ischemia and reperfusion. Mediators Inflamm (2013) 1.18

Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases. Nat Rev Drug Discov (2014) 1.17

Ischemic neurons recruit natural killer cells that accelerate brain infarction. Proc Natl Acad Sci U S A (2014) 1.16

Genetically induced moderate inhibition of the proteasome in cardiomyocytes exacerbates myocardial ischemia-reperfusion injury in mice. Circ Res (2012) 1.15

Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart. Proc Natl Acad Sci U S A (2013) 1.12

Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury. J Immunol (2013) 1.11

CD73+ regulatory T cells contribute to adenosine-mediated resolution of acute lung injury. FASEB J (2013) 1.10

Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice. Clin Exp Immunol (2014) 1.04

Processes of sterile inflammation. J Immunol (2013) 1.04

Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury. Hepatology (2015) 1.04

The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi. Blood (2013) 1.03

Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury. FASEB J (2013) 1.02

CXCR2: From Bench to Bedside. Front Immunol (2012) 1.01

Activation of parenchymal CD47 promotes renal ischemia-reperfusion injury. J Am Soc Nephrol (2012) 0.99

Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning. Proc Natl Acad Sci U S A (2012) 0.99

MicroRNA-687 Induced by Hypoxia-Inducible Factor-1 Targets Phosphatase and Tensin Homolog in Renal Ischemia-Reperfusion Injury. J Am Soc Nephrol (2015) 0.98

A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation. Blood (2013) 0.98

Sodium tanshinone IIA silate inhibits oxygen-glucose deprivation/recovery-induced cardiomyocyte apoptosis via suppression of the NF-κB/TNF-α pathway. Br J Pharmacol (2013) 0.97

Extracellular nucleotide and nucleoside signaling in vascular and blood disease. Blood (2014) 0.97

Retracted Adora2b adenosine receptor signaling protects during acute kidney injury via inhibition of neutrophil-dependent TNF-α release. J Immunol (2012) 0.97

Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1. Arterioscler Thromb Vasc Biol (2012) 0.96

Transcriptional control of adenosine signaling by hypoxia-inducible transcription factors during ischemic or inflammatory disease. J Mol Med (Berl) (2012) 0.96

Hypoxia signaling during intestinal ischemia and inflammation. Curr Opin Crit Care (2012) 0.95

Renal telocytes contribute to the repair of ischemically injured renal tubules. J Cell Mol Med (2014) 0.95

The protective effect of baicalin against renal ischemia-reperfusion injury through inhibition of inflammation and apoptosis. BMC Complement Altern Med (2014) 0.95

Ischemia-reperfusion injury in stroke. Interv Neurol (2013) 0.94

Bruton's tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury. Nat Commun (2015) 0.94

Resistance to systemic inflammation and multi organ damage after global ischemia/reperfusion in the arctic ground squirrel. PLoS One (2014) 0.94

Cytochrome P450 drives a HIF-regulated behavioral response to reoxygenation by C. elegans. Science (2013) 0.94

Attenuating myocardial ischemia by targeting A2B adenosine receptors. Trends Mol Med (2013) 0.94

Ultrasound-mediated drug delivery for cardiovascular disease. Expert Opin Drug Deliv (2013) 0.93

Soluble TNF receptors are associated with infarct size and ventricular dysfunction in ST-elevation myocardial infarction. PLoS One (2013) 0.93

Cardiac Per2 functions as novel link between fatty acid metabolism and myocardial inflammation during ischemia and reperfusion injury of the heart. PLoS One (2013) 0.92

The role of PPARα in metformin-induced attenuation of mitochondrial dysfunction in acute cardiac ischemia/reperfusion in rats. Int J Mol Sci (2012) 0.92

Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice. Gastroenterology (2013) 0.92

Aag-initiated base excision repair promotes ischemia reperfusion injury in liver, brain, and kidney. Proc Natl Acad Sci U S A (2014) 0.91

Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury. J Immunol (2012) 0.91

Oxidative Stress and Lung Ischemia-Reperfusion Injury. Oxid Med Cell Longev (2015) 0.91

Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment. World J Transplant (2015) 0.90

Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion. J Mol Cell Cardiol (2014) 0.90

The anti-oxidative role of micro-vesicles derived from human Wharton-Jelly mesenchymal stromal cells through NOX2/gp91(phox) suppression in alleviating renal ischemia-reperfusion injury in rats. PLoS One (2014) 0.90

Mesenchymal stromal cells in transplantation rejection and tolerance. Cold Spring Harb Perspect Med (2013) 0.90

Emerging roles of propolis: antioxidant, cardioprotective, and antiangiogenic actions. Evid Based Complement Alternat Med (2013) 0.90

Minor Postoperative Increases of Creatinine Are Associated with Higher Mortality and Longer Hospital Length of Stay in Surgical Patients. Anesthesiology (2015) 0.89

Picroside II protects rat kidney against ischemia/reperfusion-induced oxidative stress and inflammation by the TLR4/NF-κB pathway. Exp Ther Med (2015) 0.89

The role of sirtuins in cardiac disease. Am J Physiol Heart Circ Physiol (2015) 0.89

Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection. Cardiovasc Diabetol (2013) 0.89

Helminths and immunological tolerance. Transplantation (2014) 0.89

Hypoxia and inflammation are two sides of the same coin. Proc Natl Acad Sci U S A (2013) 0.89

Obstructive sleep apnea and coronary artery disease: from pathophysiology to clinical implications. Pulm Med (2013) 0.89

Glibenclamide Administration Attenuates Infarct Volume, Hemispheric Swelling, and Functional Impairments following Permanent Focal Cerebral Ischemia in Rats. Stroke Res Treat (2012) 0.89

Exendin-4 reduces ischemic brain injury in normal and aged type 2 diabetic mice and promotes microglial M2 polarization. PLoS One (2014) 0.89

Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion. Hepatology (2013) 0.88

Targeting cell signaling and apoptotic pathways by luteolin: cardioprotective role in rat cardiomyocytes following ischemia/reperfusion. Nutrients (2012) 0.88

All's well that transcribes well: non-coding RNAs and post-stroke brain damage. Neurochem Int (2013) 0.88

Anoxia-reoxygenation regulates mitochondrial dynamics through the hypoxia response pathway, SKN-1/Nrf, and stomatin-like protein STL-1/SLP-2. PLoS Genet (2013) 0.88

H2O2-responsive molecularly engineered polymer nanoparticles as ischemia/reperfusion-targeted nanotherapeutic agents. Sci Rep (2013) 0.88

Putative role of protein kinase C in neurotoxic inflammation mediated by extracellular heat shock protein 70 after ischemia-reperfusion. J Neuroinflammation (2014) 0.88

Mesenchymal stromal cells in renal ischemia/reperfusion injury. Front Immunol (2012) 0.87

Combination of mild hypothermia with neuroprotectants has greater neuroprotective effects during oxygen-glucose deprivation and reoxygenation-mediated neuronal injury. Sci Rep (2014) 0.87

Pre-conditioning with synthetic CpG-oligonucleotides attenuates myocardial ischemia/reperfusion injury via IL-10 up-regulation. Basic Res Cardiol (2013) 0.87

Xenon treatment protects against cold ischemia associated delayed graft function and prolongs graft survival in rats. Am J Transplant (2013) 0.87

Bioreducible polymers for therapeutic gene delivery. J Control Release (2014) 0.87

The innate immune system after ischemic injury: lessons to be learned from the heart and brain. JAMA Neurol (2014) 0.87

Anesthetic cardioprotection: the role of adenosine. Curr Pharm Des (2014) 0.87

Honokiol protects rat hearts against myocardial ischemia reperfusion injury by reducing oxidative stress and inflammation. Exp Ther Med (2012) 0.87

Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury. Am J Physiol Renal Physiol (2014) 0.87

Inhibition of a SNARE-sensitive pathway in astrocytes attenuates damage following stroke. J Neurosci (2013) 0.87

Calcium-activated potassium channels in ischemia reperfusion: a brief update. Front Physiol (2014) 0.87

HIF-1α signaling activation by post-ischemia treatment with astragaloside IV attenuates myocardial ischemia-reperfusion injury. PLoS One (2014) 0.87

Concise review: therapeutic potential of adipose tissue-derived angiogenic cells. Stem Cells Transl Med (2012) 0.87

Articles cited by this

(truncated to the top 100)

Myocardial reperfusion injury. N Engl J Med (2007) 13.41

Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (2009) 10.47

Complement: a key system for immune surveillance and homeostasis. Nat Immunol (2010) 10.37

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science (2009) 10.30

Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med (2008) 9.40

Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol (2010) 8.87

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet (2000) 8.79

Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol (2007) 7.86

Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem (2008) 7.71

Hypoxia and inflammation. N Engl J Med (2011) 7.71

The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov (2008) 7.58

Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med (2007) 7.27

Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med (2007) 6.61

The immunology of stroke: from mechanisms to translation. Nat Med (2011) 6.53

Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature (2002) 6.50

Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov (2007) 6.28

Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science (1999) 6.20

ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science (2006) 6.00

Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell (2009) 5.91

Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science (2010) 5.84

Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A (2007) 5.36

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A (2000) 5.20

MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science (2009) 5.07

Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature (2009) 4.98

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet (2010) 4.90

Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med (2009) 4.87

TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest (2007) 4.77

Cell death. N Engl J Med (2009) 4.75

Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation (2006) 4.61

Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med (2008) 4.55

Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell (2009) 4.50

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med (2007) 4.39

Postconditioning the human heart. Circulation (2005) 4.35

Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science (2008) 4.32

Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med (2004) 4.16

Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis. Nature (2010) 4.10

Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. JAMA (2011) 4.09

Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci U S A (2006) 4.08

Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci U S A (2009) 3.99

Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet (2008) 3.94

H2S induces a suspended animation-like state in mice. Science (2005) 3.93

Life with oxygen. Science (2007) 3.88

The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med (2003) 3.85

Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med (2003) 3.71

Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors. Circulation (2007) 3.65

TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med (2008) 3.62

Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med (2003) 3.54

miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med (2010) 3.50

Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest (2005) 3.48

Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med (2009) 3.32

Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol (2009) 3.24

Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest (2007) 3.22

Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation (2008) 3.13

The therapeutic potential of carbon monoxide. Nat Rev Drug Discov (2010) 3.03

Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA (2007) 2.99

Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation (2005) 2.99

Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature (2008) 2.96

Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nat Med (2009) 2.93

Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood (2004) 2.80

In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol (2002) 2.76

Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med (2009) 2.76

A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood (2007) 2.70

Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation (2003) 2.68

HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood (2008) 2.52

The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med (2008) 2.43

Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc Natl Acad Sci U S A (2009) 2.42

Identification of the target self-antigens in reperfusion injury. J Exp Med (2006) 2.38

A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest (2003) 2.32

A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med (2010) 2.31

Vascular ischaemia and reperfusion injury. Br Med Bull (2004) 2.28

miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med (2011) 2.24

ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res (2006) 2.23

Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma. J Immunol (2006) 2.22

Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol (2008) 2.15

The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest (1990) 2.12

CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation (2007) 2.09

Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages. J Exp Med (2006) 2.07

Profound cardioprotection with chloramphenicol succinate in the swine model of myocardial ischemia-reperfusion injury. Circulation (2010) 2.06

Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol (2005) 2.06

In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat Med (2010) 2.01

Adenosine: an old drug newly discovered. Anesthesiology (2009) 1.99

Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. J Am Coll Cardiol (2009) 1.98

Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A (2009) 1.95

Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia. J Am Soc Nephrol (2007) 1.90

Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J Neuroimmunol (1994) 1.85

Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J Clin Invest (1990) 1.84

Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood (2008) 1.79

Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J Am Soc Nephrol (2010) 1.77

Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS One (2007) 1.77

Infarct-sparing effect of A2A-adenosine receptor activation is due primarily to its action on lymphocytes. Circulation (2005) 1.75

Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. J Clin Invest (2010) 1.74

Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol (2008) 1.68

Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am J Physiol Heart Circ Physiol (2006) 1.68

The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. Nat Med (2005) 1.66

Long-term benefit of postconditioning. Circulation (2008) 1.65

Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation. Blood (2010) 1.65

Cutting Edge: A2B Adenosine receptor signaling provides potent protection during intestinal ischemia/reperfusion injury. J Immunol (2009) 1.63

Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J (2008) 1.63

Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci U S A (2007) 1.61

Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease. Blood (2010) 1.56

Articles by these authors

Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal (2006) 2.98

The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med (2008) 2.43

ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res (2006) 2.23

CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation (2007) 2.09

Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia. J Am Soc Nephrol (2007) 1.90

Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J (2007) 1.84

Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood (2008) 1.79

Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J Immunol (2010) 1.70

Myocardial ischemia reperfusion injury: from basic science to clinical bedside. Semin Cardiothorac Vasc Anesth (2012) 1.52

Nucleotide metabolism and cell-cell interactions. Methods Mol Biol (2006) 1.27

Direct treatment of mouse or human blood with soluble 5'-nucleotidase inhibits platelet aggregation. Arterioscler Thromb Vasc Biol (2008) 1.15

Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo. PLoS One (2009) 1.09

Interplay of hypoxia and A2B adenosine receptors in tissue protection. Adv Pharmacol (2011) 1.07

Ganciclovir-resistant cytomegalovirus disease after allogeneic stem cell transplantation: pitfalls of phenotypic diagnosis by in vitro selection of an UL97 mutant strain. J Infect Dis (2002) 1.05

Impact of ischemia and reperfusion times on myocardial infarct size in mice in vivo. Exp Biol Med (Maywood) (2008) 1.02

The hypoxia-inflammation link and potential drug targets. Curr Opin Anaesthesiol (2011) 0.97

Lack of effect of extracellular adenosine generation and signaling on renal erythropoietin secretion during hypoxia. Am J Physiol Renal Physiol (2007) 0.94

Use of a hanging-weight system for isolated renal artery occlusion during ischemic preconditioning in mice. Am J Physiol Renal Physiol (2006) 0.94

Attenuating myocardial ischemia by targeting A2B adenosine receptors. Trends Mol Med (2013) 0.94

Cardiac Per2 functions as novel link between fatty acid metabolism and myocardial inflammation during ischemia and reperfusion injury of the heart. PLoS One (2013) 0.92

Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injury. Anesthesiology (2012) 0.91

Upregulation of the water channel aquaporin-4 as a potential cause of postischemic cell swelling in a murine model of myocardial infarction. Cardiology (2007) 0.89

Cardiac period 2 in myocardial ischemia: clinical implications of a light dependent protein. Int J Biochem Cell Biol (2013) 0.84

PHD2 mutation and congenital erythrocytosis with paraganglioma. N Engl J Med (2009) 0.84

High impact of an expanded restriction fragment length polymorphism assay on detection of ganciclovir-resistant UL97 mutants of human cytomegalovirus. Antimicrob Agents Chemother (2003) 0.82

Toll-like receptor signaling during myocardial ischemia. Anesthesiology (2011) 0.82

Pressure controlled ventilation to induce acute lung injury in mice. J Vis Exp (2011) 0.81

Health implications of disrupted circadian rhythms and the potential for daylight as therapy. Anesthesiology (2015) 0.80

Analysis of selected sugars and sugar phosphates in mouse heart tissue by reductive amination and liquid chromatography-electrospray ionization mass spectrometry. Anal Chem (2013) 0.76

Metabolomic analysis of key central carbon metabolism carboxylic acids as their 3-nitrophenylhydrazones by UPLC/ESI-MS. Electrophoresis (2013) 0.76

Management of chronic obstructive pulmonary disease. N Engl J Med (2004) 0.75

The HIF2A gene in familial erythrocytosis. N Engl J Med (2008) 0.75

Next generation of cardiovascular studies: transcriptional responses of the human myocardium during cardiac surgery. Anesthesiology (2015) 0.75